Publisher Correction: Exploring the significance of interleukin-33/ST2 axis in minimal change disease. [PDF]
Kanazawa N +5 more
europepmc +1 more source
Predictive value of serum interleukin-33 and thymic stromal lymphopoietin for the risk of acute exacerbation in patients with chronic obstructive pulmonary disease. [PDF]
Yin S, Xu K, Wu S, Liu H, Ding Z.
europepmc +1 more source
RETRACTION: Interleukin-33 Links Asthma to Alopecia Areata: Mendelian Randomization and Mediation Analysis. [PDF]
europepmc +1 more source
Interleukin 33 Promotes Liver Sinusoidal Endothelial Cell Dysfunction and Hepatic Fibrosis in Diabetic Mice. [PDF]
Chen H +13 more
europepmc +1 more source
Interleukin-33 promotes lipolysis of adipocytes and protects male mice against obesity via activation of β-adrenergic receptor signaling. [PDF]
Chen Q +6 more
europepmc +1 more source
Partial reduction of interleukin-33 signaling improves senescence and renal injury in diabetic nephropathy. [PDF]
Chen L +15 more
europepmc +1 more source
Predictive value of low serum interleukin-33 levels in acute ischemic stroke outcomes. [PDF]
Liu W, Luo D, Liu X, Zhang Y, Wang Z.
europepmc +1 more source
Dual Time-Dependent Effects of Interleukin-33 Administration on the Kidney Postmyocardial Infarction. [PDF]
Amin G +5 more
europepmc +1 more source
Soluble interleukin-33 receptor (sST-2): a novel marker for assessing cardiovascular risk in rheumatoid arthritis. [PDF]
Claus I +7 more
europepmc +1 more source
Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth. [PDF]
Donahue KL +26 more
europepmc +1 more source

